Story
BUSINESS · NOV 2, 2026
Accendra Health Extends $150 Million Receivables Sale Program
Accendra Health extended the termination date of its $150 million receivables sale program to October 2029, triggering a 21% rise in premarket share price.
Accendra Health, Inc. amended its receivables sale program to extend the facility's scheduled termination date to October 2029. The company maintained the existing size of the program at $150 million.
Following the announcement, shares of Accendra Health rose nearly 21% in premarket trading, reaching a price of $0.31.
Reported across 2 outlets
Actors
Accendra Health, Inc.
